Self-testing has proven to be highly effective in improving patient outcomes and avoiding potentially serious and costly complications due to fluctuating INR values.

• CMS states, "...in order to achieve time in therapeutic range of >90%, a patient most likely needs to be tested once a week."

• Frequent testing can help reduce the incidence of anticoagulation-related complications, thereby reducing the cost of therapy.

• Convenient for patients to test anytime, anywhere for improved patient compliance.

ITC has partnered with three leading providers that function as the liaison between you and your patient. The provider furnishes patient supplies, obtains insurance coverage, and sends you weekly results for evaluation and management so you can obtain reimbursement.

QAS, Inc. - 1-800-563-5680 or www.protimetest.com
Philips - 1-877-729-8350 or www.inrselftest.com

ZyCare - 1-866-419-7228

www.coagcare.com

References